Current and emerging treatments for vitiligo.
Identifieur interne : 000969 ( PubMed/Curation ); précédent : 000968; suivant : 000970Current and emerging treatments for vitiligo.
Auteurs : Michelle Rodrigues [Australie] ; Khaled Ezzedine [France] ; Iltefat Hamzavi [États-Unis] ; Amit G. Pandya [États-Unis] ; John E. Harris [États-Unis]Source :
- Journal of the American Academy of Dermatology [ 1097-6787 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- therapy : Vitiligo.
- Algorithms, Humans, Treatment Outcome.
Abstract
Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.
DOI: 10.1016/j.jaad.2016.11.010
PubMed: 28619557
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000972
Links to Exploration step
pubmed:28619557Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Current and emerging treatments for vitiligo.</title><author><name sortKey="Rodrigues, Michelle" sort="Rodrigues, Michelle" uniqKey="Rodrigues M" first="Michelle" last="Rodrigues">Michelle Rodrigues</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria, Australia. Electronic address: dr.rodrigues@gmail.com.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Ezzedine, Khaled" sort="Ezzedine, Khaled" uniqKey="Ezzedine K" first="Khaled" last="Ezzedine">Khaled Ezzedine</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil</wicri:regionArea></affiliation></author><author><name sortKey="Hamzavi, Iltefat" sort="Hamzavi, Iltefat" uniqKey="Hamzavi I" first="Iltefat" last="Hamzavi">Iltefat Hamzavi</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Dermatology, Henry Ford Hospital, Detroit</wicri:cityArea></affiliation></author><author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G" last="Pandya">Amit G. Pandya</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas</wicri:cityArea></affiliation></author><author><name sortKey="Harris, John E" sort="Harris, John E" uniqKey="Harris J" first="John E" last="Harris">John E. Harris</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Dermatology, University of Massachusetts Medical School, Worcester</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28619557</idno><idno type="pmid">28619557</idno><idno type="doi">10.1016/j.jaad.2016.11.010</idno><idno type="wicri:Area/PubMed/Corpus">000972</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000972</idno><idno type="wicri:Area/PubMed/Curation">000969</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000969</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Current and emerging treatments for vitiligo.</title><author><name sortKey="Rodrigues, Michelle" sort="Rodrigues, Michelle" uniqKey="Rodrigues M" first="Michelle" last="Rodrigues">Michelle Rodrigues</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria, Australia. Electronic address: dr.rodrigues@gmail.com.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Ezzedine, Khaled" sort="Ezzedine, Khaled" uniqKey="Ezzedine K" first="Khaled" last="Ezzedine">Khaled Ezzedine</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil</wicri:regionArea></affiliation></author><author><name sortKey="Hamzavi, Iltefat" sort="Hamzavi, Iltefat" uniqKey="Hamzavi I" first="Iltefat" last="Hamzavi">Iltefat Hamzavi</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Dermatology, Henry Ford Hospital, Detroit</wicri:cityArea></affiliation></author><author><name sortKey="Pandya, Amit G" sort="Pandya, Amit G" uniqKey="Pandya A" first="Amit G" last="Pandya">Amit G. Pandya</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas</wicri:cityArea></affiliation></author><author><name sortKey="Harris, John E" sort="Harris, John E" uniqKey="Harris J" first="John E" last="Harris">John E. Harris</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Dermatology, University of Massachusetts Medical School, Worcester</wicri:cityArea></affiliation></author></analytic><series><title level="j">Journal of the American Academy of Dermatology</title><idno type="eISSN">1097-6787</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithms</term><term>Humans</term><term>Treatment Outcome</term><term>Vitiligo (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Algorithmes</term><term>Humains</term><term>Résultat thérapeutique</term><term>Vitiligo ()</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Vitiligo</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Algorithms</term><term>Humans</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Algorithmes</term><term>Humains</term><term>Résultat thérapeutique</term><term>Vitiligo</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28619557</PMID><DateCreated><Year>2017</Year><Month>06</Month><Day>16</Day></DateCreated><DateCompleted><Year>2017</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2017</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-6787</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of the American Academy of Dermatology</Title><ISOAbbreviation>J. Am. Acad. Dermatol.</ISOAbbreviation></Journal><ArticleTitle>Current and emerging treatments for vitiligo.</ArticleTitle><Pagination><MedlinePgn>17-29</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0190-9622(16)31095-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaad.2016.11.010</ELocationID><Abstract><AbstractText>Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.</AbstractText><CopyrightInformation>Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, St. Vincent's Hospital, The Skin and Cancer Foundation Inc, Victoria, Australia; The Royal Children's Hospital, Victoria, Australia. Electronic address: dr.rodrigues@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezzedine</LastName><ForeName>Khaled</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Henri Mondor Hospital, Creteil, France; EpiDermE, Universite Paris-Est, Creteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamzavi</LastName><ForeName>Iltefat</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandya</LastName><ForeName>Amit G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Vitiligo Working Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Acad Dermatol</MedlineTA><NlmUniqueID>7907132</NlmUniqueID><ISSNLinking>0190-9622</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014820" MajorTopicYN="N">Vitiligo</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">afamelanotide</Keyword><Keyword MajorTopicYN="N">biologics</Keyword><Keyword MajorTopicYN="N">corticosteroids</Keyword><Keyword MajorTopicYN="N">excimer lamp</Keyword><Keyword MajorTopicYN="N">excimer laser</Keyword><Keyword MajorTopicYN="N">grafting</Keyword><Keyword MajorTopicYN="N">leukoderma</Keyword><Keyword MajorTopicYN="N">methotrexate</Keyword><Keyword MajorTopicYN="N">narrowband ultraviolet light</Keyword><Keyword MajorTopicYN="N">phototherapy</Keyword><Keyword MajorTopicYN="N">pigmentation</Keyword><Keyword MajorTopicYN="N">tacrolimus</Keyword><Keyword MajorTopicYN="N">treatment</Keyword><Keyword MajorTopicYN="N">vitiligo</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28619557</ArticleId><ArticleId IdType="pii">S0190-9622(16)31095-7</ArticleId><ArticleId IdType="doi">10.1016/j.jaad.2016.11.010</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000969 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000969 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:28619557
|texte= Current and emerging treatments for vitiligo.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28619557" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |